Skip to main content
SpringerLink
Log in

Arterielle Hypertonie

  • Chapter
Klinische Kardiologie

  • 1378 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • ALLHAT (2002) The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high risc hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288: 2981–2997

    Google Scholar 

  • Andersson OK, Almgren T, Persson B et al. (1998) Survival in treated hypertension: follow up study after two decades. BMJ 317: 167–171

    PubMed  CAS  Google Scholar 

  • Black HR, Kuller LH, O’Rourke MF et al. (1999) The first report of the Systolic and Pulse Pressure (SYPP) Working Group. J Hypertens 17(Suppl 5): 3–14

    Google Scholar 

  • Dahlöf B, Deveraux RB, Kjeldsen SE (2002) Cardiovascular morbidity and mortality the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995–1003

    PubMed  Google Scholar 

  • Deutschen Liga zur Bekämpfung des hohen Blutdruckes e.V. D-H-G (1998) Sektion Blutdruckmessung und Hochdruckdiagnostik. Ambulante 24-h-Blutdruckmessung (ABDM). Dt Med Wochenschr 123: 1426–1428

    Google Scholar 

  • Domanski MJ, Davis BR, Pfeffer MA et al. (1999) Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension 34: 375–380

    PubMed  CAS  Google Scholar 

  • ESH-ESC-Guidelines (2003) European Society of Hypertension — European society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens 21: 1011–1053

    Google Scholar 

  • Gasse C, Stieber J, Doring A et al. (1999) Population trends in antihypertensive drug use: results from the MONICA Augsburg Project 1984 to 1995. J Clin Epidemiol 52: 695–703

    Article  PubMed  CAS  Google Scholar 

  • Geiger H, Naraghi R, Schobel HP et al. (1998) Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet 352: 446–449

    PubMed  CAS  Google Scholar 

  • Gosse P, Sheridan PJ, Zannad F et al. (2000) Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg, the LIVE study. J Hypertens 18: 1465–1475

    Article  PubMed  CAS  Google Scholar 

  • Gueyffier F, Bulpitt C, Boissel JP et al. (1999) Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet 353: 793–796

    PubMed  CAS  Google Scholar 

  • Hansson L, Zanchetti A, Carruthers SG et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351: 1755–1762

    Article  PubMed  CAS  Google Scholar 

  • Hansson L, Lindholm LH, Ekbom T et al. (1999a) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354: 1751–1756

    PubMed  CAS  Google Scholar 

  • Hansson L, Lindholm LH, Niskanen L et al. (1999b) Effect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353: 611–616

    PubMed  CAS  Google Scholar 

  • HOPE Study Investigators (2000) New Engl J Med 342: 145–153

    Google Scholar 

  • Jackson R (2000) Guidelines on preventing cardiovascular disease in clinical practice. BMJ 320: 659–661

    PubMed  CAS  Google Scholar 

  • Joint-National-Committee (2003) The 7th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 289: 2560–2572

    Google Scholar 

  • Jonsson B, Johannesson M (1999) Cost benefit of treating hypertension. Clin Exp Hypertens A 21: 987–997

    Article  CAS  Google Scholar 

  • Kannel WB (1996) Blood pressure as a cardiovascular risk factor. JAMA 275: 1571–1576

    Article  PubMed  CAS  Google Scholar 

  • Koren MJ, Devereux RB, Casale PN et al. (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345–352

    PubMed  CAS  Google Scholar 

  • Krijnen P, Jaarsveld BC van, Steyerberg EW et al. (1998) A clinical prediction rule for renal artery stenosis. Ann Intern Med 129: 705–711

    PubMed  CAS  Google Scholar 

  • MacMahon S, Peto R, Cutler J et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765–774

    Article  PubMed  CAS  Google Scholar 

  • Maisonneuve P, Agodoa L, Gellert R et al. (2000) Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 35: 157–165

    PubMed  CAS  Google Scholar 

  • MERIT-HF (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure. Lancet 353: 2001–2007

    Google Scholar 

  • Mundal R, Kjeldsen SE, Sandvik L et al. (1994) Exercise blood pressure predicts cardiovascular mortality in middle-aged men. Hypertension 24: 56–62

    PubMed  CAS  Google Scholar 

  • Nakao N, Yoshimura A, Morita H et al. (2003) Combination treatment of angiotensin-II-receptor blocker and agiotensin converting enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controled trial). Lancet 361: 117–124

    PubMed  CAS  Google Scholar 

  • Ohkubo T, Imai Y, Tsuji I et al. (1998) Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement:a population-based observation in Ohasama, Japan. J Hypertens 16: 971–975

    Article  PubMed  CAS  Google Scholar 

  • Ollenschläger G, Oesingmann U, Thomeczek C et al. (1998) Leitlinien und Evidence-based Medicine in Deutschland. Münchner Med Wochenschr 140: 30–33

    Google Scholar 

  • Peterson JC, Adler S, Burkart JM et al. (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123: 754–762

    PubMed  CAS  Google Scholar 

  • PROGRESS Collaborative Group (2001) Randomized trial of a perindoprilbased blood-pressure-lowering regimen among 6.105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1041

    Google Scholar 

  • Rodgers A, MacMahon S, Gamble G (1996) Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ 313:147

    Google Scholar 

  • Rodgers A et al. (1997) The effects of blood pressure lowering in cerebrovascular disease. Neuro Rev Int 2:12

    Google Scholar 

  • Sacks FM, Svetkey LP, Vollmer WM et al. (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344: 3–10

    Article  PubMed  CAS  Google Scholar 

  • Schellinger PD, Steiner T (1998) Emergency and intensive care treatment after stroke. Recommendations of the European Consensus Group. Nervenarzt 69: 530–539

    Article  PubMed  CAS  Google Scholar 

  • Staessen JA, Fagard R, Thijs L et al. (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350: 757–764

    PubMed  CAS  Google Scholar 

  • Staessen JA, Thijs L, Fagard R et al. (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 282: 539–546

    Article  PubMed  CAS  Google Scholar 

  • Staessen JA, Wang J, Thijs L (2003) Cardiovascular prevention and blood pressure reduction: a qualitative overview updated until 1 March 2003. J Hypertens 21: 1055–1076

    PubMed  CAS  Google Scholar 

  • UKPDS (1998) UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352: 854–865

    Google Scholar 

  • Van den Hoogen PC, Feskens EJ, Nagelkerke NJ et al. (2000) The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 342: 1–8

    PubMed  Google Scholar 

  • Vasan RS, Benjamin EJ, Levy D (1995) Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 26: 1565–1574

    Article  PubMed  CAS  Google Scholar 

  • WHO/ISH-Guidelines-Subcommittee (1999) World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17: 151–183

    Google Scholar 

  • Yusuf S, Sleight P, Pogue J et al. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145–153

    PubMed  CAS  Google Scholar 

  • Zanchetti A (1995) What have we learnt and what haven’t we from clinical trials on hypertension? In: Laragh JH, Brenner BM (eds) Hypertension, pathophysiology, diagnosis and management, 2nd edn. Raven, New York, pp 2509–2529

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik III für Innere Medizin, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Germany

    F. M. Baer

Authors
  1. F. M. Baer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik III für Innere Medizin, Klinikum der Universität zu Köln, Kerpener Str. 62, 50937, Köln, Germany

    Erland Erdmann

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Baer, F.M. (2006). Arterielle Hypertonie. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_7

Download citation

  • DOI: https://doi.org/10.1007/3-540-29425-2_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23742-6

  • Online ISBN: 978-3-540-29425-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation